Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
104607-7 MDS v3.0 - RAI v1.19.1 - Swing Bed discharge (SD) item set - ^Patient RptPeriod - CMS Assessment &nbsp; ACTIVE MDS v3.0 - RAI v1.19.1 - Swing Bed discharge (SD) item set during assessment period [CMS Assessment] &nbsp; PANEL DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CMS &nbsp; 104607-7 &nbsp; CMS Assessment &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Centers for Medicare and Medicaid Assessment; Disch; MDS v3.0 - RAI v1.19.1 - SD; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey 2.81 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104608-5 MDS v3.0 - RAI v1.19.1 - Interim Payment Assessment (IPA) item set - ^Patient RptPeriod - CMS Assessment &nbsp; ACTIVE MDS v3.0 - RAI v1.19.1 - Interim Payment Assessment (IPA) item set during assessment period [CMS Assessment] &nbsp; PANEL DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CMS &nbsp; 104608-5 &nbsp; CMS Assessment &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Centers for Medicare and Medicaid Assessment; MDS v3.0 - RAI v1.19.1 - IPA; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey 2.81 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
105008-7 MDS v3.0 - RAI v1.19.1 - Nursing home and Swing bed tracking (NT ST) item set - ^Patient RptPeriod - CMS Assessment &nbsp; ACTIVE MDS v3.0 - RAI v1.19.1 - Nursing home and Swing bed tracking (NT ST) item set during assessment period [CMS Assessment] &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CMS &nbsp; 105008-7 &nbsp; CMS Assessment &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Centers for Medicare and Medicaid Assessment; MDS v3.0 - RAI v1.19.1 - NT & ST; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey 2.78 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104873-5 Glucose dumping syndrome panel - Ser/Plas/Bld Pt - &nbsp; &nbsp; ACTIVE Glucose dumping syndrome panel - Serum, Plasma or Blood &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.HEM/BC &nbsp; 104873-5 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 GDS pnl SerPlBld &nbsp; &nbsp; &nbsp; N &nbsp; Blood; GDS pnl; Glu; Gluc; Glucoseur; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pl; PlasBld; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood 2.78 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104609-3 MDS v3.0 - RAI v1.19.1 - Swing bed PPS (SP) item set - ^Patient RptPeriod - CMS Assessment &nbsp; ACTIVE MDS v3.0 - RAI v1.19.1 - Swing bed PPS (SP) item set during assessment period [CMS Assessment] &nbsp; PANEL DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CMS &nbsp; 104609-3 &nbsp; CMS Assessment &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Centers for Medicare and Medicaid Assessment; MDS v3.0 - RAI v1.19.1 - SP; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; species; spp; Survey 2.81 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104884-2 Tubular reabsorption of phosphorus panel - Urine+Ser/Plas Pt - &nbsp; &nbsp; ACTIVE Tubular reabsorption of phosphorus panel - Urine and Serum or Plasma &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CHEM &nbsp; 104884-2 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Tubular reabsorp phos pnl Ur+SerPl &nbsp; &nbsp; &nbsp; N &nbsp; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TmP; Tubular reabsorp phos pnl; UA; UR; Ur+SerPl; Urn 2.78 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104626-7 Methadone Confirmatory panel - Urine Pt - &nbsp; &nbsp; ACTIVE Methadone Confirmatory panel - Urine &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.DRUG/TOX &nbsp; 104626-7 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Methadone Confirmatory pnl Ur &nbsp; &nbsp; &nbsp; N &nbsp; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; METD; Methadone Confirmatory pnl; Methadose; MTD; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn 2.78 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104632-5 Metanephrine & Normetanephrine & Total metanephrines panel - Urine 24H - &nbsp; &nbsp; ACTIVE Metanephrine, Normetanephrine and Total metanephrines panel - 24 hour Urine &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CHEM &nbsp; 104632-5 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Met+normet+ tot met pnl 24h Ur &nbsp; &nbsp; &nbsp; N &nbsp; 1 day; 24 hours; 24HR; Chemistry; Met+normet+ tot met pnl; Metaneph; Metaneph+Normetaneph; Metanephrine fractionated; Metanephrine+normetanephrine; Metanephrne; MetanephS; Metenephrine; Normeta; Normetaneph; Normetanephrn; Pan; PANEL.CHEMISTRY; Panl; Pnl; Tot; Totl; UA; UR; Urn 2.78 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104922-0 Laboratory test details panel - ^Patient Pt - &nbsp; &nbsp; ACTIVE Laboratory test details panel &nbsp; PANEL DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.ADMIN &nbsp; 104922-0 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Laboratory test details panel &nbsp; &nbsp; &nbsp; N &nbsp; ADMIN; Pan; PANEL.ADMIN; Panl; Pnl; Point in time; Random 2.79 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.79: ORDER_OBS: Panel code; 0
104956-8 Communication capability information panel - ^Patient Pt - &nbsp; &nbsp; ACTIVE Communication capability information panel &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.ADMIN &nbsp; 104956-8 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Comm capability info panel &nbsp; &nbsp; &nbsp; N &nbsp; ADMIN; Comm capability info panel; Pan; PANEL.ADMIN; Panl; Pnl; Point in time; Random 2.78 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104651-5 Herpes simplex virus 1 & 2 & Varicella zoster virus & Treponema pallidum DNA panel - ^Patient Pt - Probe.amp.tar &nbsp; ACTIVE Herpes simplex virus 1 and 2 and Varicella zoster virus and Treponema pallidum DNA panel by NAA with probe detection &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.MICRO &nbsp; 104651-5 &nbsp; Probe.amp.tar &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 HSV 1 + 2 + VZV+T pall pnl NAA+probe &nbsp; &nbsp; &nbsp; N &nbsp; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; Herpes zoster; HHV-3; HSV; HSV 1 + 2 + VZV+T pall pnl; HSV 1+2; HSV1; HSV1+2; Human herpesvirus 3; i; II; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Shingles; Strand Displacement Amplification; Syphilis; T pallidum; TMA; Transcription mediated amplification; Treponemal; VZ; VZV; Zoster 2.78 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104657-2 Sialate free and total panel - Urine Pt - &nbsp; &nbsp; ACTIVE Sialate free and total panel - Urine &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CHEM &nbsp; 104657-2 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Sialate free and total pnl Ur &nbsp; &nbsp; &nbsp; N &nbsp; Chemistry; FR; N-Acetylneuraminic Acid; Non-protein bound; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; SA; Sialate free and total pnl; Sialate.free; Sialic acid; Tot; Totl; UA; UR; Urn 2.78 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104661-4 Poxvirus DNA panel - XXX Pt - Probe.amp.tar &nbsp; ACTIVE Poxvirus DNA panel - Specimen by NAA with probe detection &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.MICRO &nbsp; 104661-4 &nbsp; Probe.amp.tar &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Poxvirus DNA panel Spec NAA+probe &nbsp; &nbsp; &nbsp; N &nbsp; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified 2.78 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
103202-8 SARS coronavirus 2 RNA - Respiratory Pt - Probe.amp.tar &nbsp; DEPRECATED Deprecated SARS-CoV-2 (COVID-19) RNA in Respiratory specimen by NAA with probe detection &nbsp; DEL DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.MICRO &nbsp; 103202-8 &nbsp; Probe.amp.tar &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Deprecated SARS-CoV-2 RNA Resp NAA+probe &nbsp; &nbsp; &nbsp; N &nbsp; 2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; II; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; Panel; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus 2.76 2.75 &nbsp; Panel &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
103204-4 External Steroid panel - Ser/Plas Pt - &nbsp; &nbsp; ACTIVE External Steroid panel Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CHEM &nbsp; 103204-4 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Ext steroid pnl SerPl &nbsp; &nbsp; &nbsp; N &nbsp; Chemistry; EXT; Ext steroid pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.77 2.75 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.77: CLASS: changed class to PANEL.CHEM; 0
104673-9 Diabetes mellitus type 1 autoimmune panel - Ser/Plas Pt - &nbsp; &nbsp; ACTIVE Diabetes mellitus type 1 autoimmune panel - Serum or Plasma &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SERO &nbsp; 104673-9 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Diabetes type 1 autoimn pnl SerPl &nbsp; &nbsp; &nbsp; N &nbsp; Diabetes type 1 autoimn pnl; DM; i; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.78 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104676-2 Methylphenidate & Alpha-Phenyl-2-Piperidine acetate panel - Urine Pt - &nbsp; &nbsp; ACTIVE Methylphenidate and Alpha-Phenyl-2-Piperidine acetate panel - Urine &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.DRUG/TOX &nbsp; 104676-2 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Mthlphend & A-Phnl-2-Pprdn pnl Ur &nbsp; &nbsp; &nbsp; N &nbsp; Acetic acid; Alfa; Alpha-phenyl-2-piperidine acetic acid; DRUG/TOXICOLOGY; Drugs; Ethanoate; Ethanoic acid; II; Me-phenidate; Methylphenidate metabolite; Mthlphendt & Alph-Phnl-2-Piperdn act pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Phenylpiperidine acetate; Phenylpiperidine acetic acid; Pnl; Point in time; PPAA; Random; Ritalin; Ritalinate; Ritalinic acid; UA; UR; Urn 2.78 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104976-6 Information panel - Person Pt - &nbsp; &nbsp; ACTIVE Information panel Person &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.ADMIN &nbsp; 104976-6 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Information panel Person &nbsp; &nbsp; &nbsp; N &nbsp; ^Person; ADMIN; Pan; PANEL.ADMIN; Panl; Persons; Pnl; Point in time; Random 2.78 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104533-5 Immunoglobulin light chains.free panel - Ser/Plas Pt - &nbsp; &nbsp; ACTIVE Immunoglobulin light chains.free panel - Serum or Plasma &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CHEM &nbsp; 104533-5 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Immunoglobulin LC free Pnl SerPl &nbsp; &nbsp; &nbsp; N &nbsp; Bence Jones protein; BJ Protein; BJ Protein Free; BJP; Chain; Chemistry; FLC; FR; Immune globulin; Immuno; Immunoglob; Immunoglobin; Immunoglobulin LC free Pnl; Imunoglbon; Imunoglobn; Non-protein bound; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.78 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104535-0 Cobalamin, Methionine & Methylmalonic Acid Pathways Panel - Ser/Plas Pt - &nbsp; &nbsp; ACTIVE Cobalamin, Methionine and Methylmalonic Acid Pathways Panel - Serum or Plasma &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CHEM &nbsp; 104535-0 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Coba, methio & mma path pnl SerPl &nbsp; &nbsp; &nbsp; N &nbsp; Acd; Acids; Chemistry; Coba, methio & mma path pnl; Met; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.78 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104536-8 Egg Comprehensive Ab.IgE panel - Ser/Plas Pt - &nbsp; &nbsp; ACTIVE Egg Comprehensive IgE Ab panel - Serum or Plasma &nbsp; NAM DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.ALLERGY &nbsp; 104536-8 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Egg Comprehensive IgE pnl SerPl &nbsp; &nbsp; &nbsp; N &nbsp; Allergen; Allergens; ALLERGY TESTING; Egg Comprehensive IgE pnl; Immune globulin E; Immunoglobulin E; Pan; PANEL.ALLERGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.79 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.79: COMPONENT: Added the antibodyi; 0
104537-6 Creatine, guanidinoacetate & creatinine panel - Ser/Plas Pt - &nbsp; &nbsp; ACTIVE Creatine, guanidinoacetate and creatinine panel - Serum or Plasma &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CHEM &nbsp; 104537-6 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Cr, GAA and Creat Pnl SerPl &nbsp; &nbsp; &nbsp; N &nbsp; Chemistry; CR; Cr, GAA and Creat Pnl; Crea; Creat; Creat Pnl; GAA; glycocyamine; guanidinoacetic acid; guanidoacetic acid; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.78 2.78 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
102078-3 Chimeric antigen receptor T-cell therapy panel - XXX Pt - &nbsp; &nbsp; ACTIVE CAR-T therapy panel - Specimen &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.DRUG/TOX &nbsp; 102078-3 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 CAR-T panel Spec &nbsp; &nbsp; &nbsp; N &nbsp; Ag; CAR-T panel; DRUG/TOXICOLOGY; Drugs; Misc; Miscellaneous; Other; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Spec; T cell; T prime; To be specified in another part of the message; UCHL-1; Unspecified 2.75 2.75 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
102082-5 Alpha-1-Antitrypsin Proteotype panel - Ser/Plas Pt - &nbsp; &nbsp; ACTIVE Alpha-1-Antitrypsin Proteotype Panel - Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CHEM &nbsp; 102082-5 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 A1AT Proteotype panel SerPl &nbsp; &nbsp; &nbsp; N &nbsp; A1; A1A; A1AT; A-1-AT; A1-AT; A1AT Proteotype panel; AAT; Alfa; Alpha-1-antitrypsin.total; Alpha-1-protease inhibitor; Alpha-1-proteinase inhibitor; Alpha-1-trypsin inhibitor; Chemistry; i; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.76 2.75 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
102083-3 Arginine Stimulation XXX Challenge Panel - Ser/Plas Pt - IA &nbsp; ACTIVE Arginine stimulation challenge panel - Serum or Plasma by Immunoassay &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CHAL &nbsp; 102083-3 &nbsp; IA &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Arginine stim chal pnl SerPl IA &nbsp; &nbsp; &nbsp; N &nbsp; Arg; Arginine stim chal pnl; CHEMISTRY.CHALLENGE TESTING; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stim; SUDS 2.76 2.75 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
108,248 results found